MIRA Pharmaceuticals (NASDAQ:MIRA) stock is seeing massive gains on Monday after the pre-clinical-stage pharmaceutical company released data from its pre-clinical study of Ketamir-2.
Ketamir-2. is MIRA Pharmaceuticals’ novel oral ketamine analog. It’s being studied as a potential treatment for neurological and neuropsychiatric disorders. That includes depression, treatment-resistant depression and post-traumatic stress disorder (PTSD).
Here’s what MIRA Pharmaceuticals chairman and CEO Erez Aminov said about the new data.
“Our vision at MIRA is to transform the treatment landscape for neurological and neuropsychiatric disorders. Ketamir-2 shows great promise in addressing these debilitating conditions with improved efficacy and safety, offering new hope and better quality of life for patients and their families. Importantly, we are seeing a drumbeat of promising data this year that we hope will allow us to file an IND and begin to test our theories about Ketamir-2 in actual patients in the near term.”
What This Means for MIRA Stock
MIRA stock could benefit greatly if the company is able to move forward with its IND plans. The company’s shares are already gaining today with more than 116 million shares traded. For the record, its daily average trading volume is about 654,000 shares.
MIRA Stock is up 318.1% as of Monday afternoon.
Investors will want to stick around for more of the most recent stock market stories!
We have all of the hottest stock market news investors need to know about on Monday! Among that is what has shares of Nio (NYSE:NIO), Reddit (NYSE:RDDT) and Cassava Sciences (NASDAQ:SAVA) stock moving today. All of that info is good to go at the links below!
More Monday Stock Market News
- NIO Stock Alert: More Details Emerge About Upcoming Nio Day 2024
- RDDT Stock Alert: Reddit Nabs New Deals with NFL, NBA
- SAVA Stock Alert: Cassava Sciences Pops on Late-Stage Trial Update
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
Read More: Penny Stocks — How to Profit Without Getting Scammed
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
